Radioimmunoassay of apolipoprotein B with use of monoclonal antibodies. 1984

Y Maynard, and D C Roden, and M J Tikkanen, and G Schonfeld, and J H Ladenson

We describe a double-antibody radioimmunoassay for apolipoprotein B with use of monoclonal antibodies. Values for 32 patients with various lipid disorders, obtained with use of one of the monoclonal antibodies (464B1B6), were similar to those obtained with use of a polyclonal antiserum. When we used another monoclonal antibody (465C3D1) the values were significantly lower. Monoclonal antibody 464B1B6 recognized apolipoprotein B determinants in the very-low-density-lipoprotein and low-density-lipoprotein fractions of plasma in a similar fashion as in unfractionated plasma, but monoclonal 465C3D1 gave lower values with the fractionated plasma. For precipitation of the antibody-apolipoprotein complex to be complete, use of polyethylene glycol was necessary with one of the monoclonal antibodies but not with the other. The interassay CV was 12.3% and 11.6% for the assays with the monoclonal antibodies. Analytical recoveries ranged from 85 to 94%. Owing to variations in the B50 from one preparation of standard to another, we found it necessary to normalize the results to those of a serum pool. We conclude that certain monoclonal antibodies can be used effectively in radioimmunoassays for apolipoprotein B in plasma and may help in the standardization of these assays.

UI MeSH Term Description Entries
D006951 Hyperlipoproteinemias Conditions with abnormally elevated levels of LIPOPROTEINS in the blood. They may be inherited, acquired, primary, or secondary. Hyperlipoproteinemias are classified according to the pattern of lipoproteins on electrophoresis or ultracentrifugation. Hyperlipoproteinemia
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D008079 Lipoproteins, VLDL A class of lipoproteins of very light (0.93-1.006 g/ml) large size (30-80 nm) particles with a core composed mainly of TRIGLYCERIDES and a surface monolayer of PHOSPHOLIPIDS and CHOLESTEROL into which are imbedded the apolipoproteins B, E, and C. VLDL facilitates the transport of endogenously made triglycerides to extrahepatic tissues. As triglycerides and Apo C are removed, VLDL is converted to INTERMEDIATE-DENSITY LIPOPROTEINS, then to LOW-DENSITY LIPOPROTEINS from which cholesterol is delivered to the extrahepatic tissues. Pre-beta-Lipoprotein,Prebeta-Lipoprotein,Prebeta-Lipoproteins,Very Low Density Lipoprotein,Very-Low-Density Lipoprotein,Very-Low-Density Lipoproteins,Lipoprotein VLDL II,Lipoproteins, VLDL I,Lipoproteins, VLDL III,Lipoproteins, VLDL1,Lipoproteins, VLDL2,Lipoproteins, VLDL3,Pre-beta-Lipoproteins,Lipoprotein, Very-Low-Density,Lipoproteins, Very-Low-Density,Pre beta Lipoprotein,Pre beta Lipoproteins,Prebeta Lipoprotein,Prebeta Lipoproteins,VLDL Lipoproteins,VLDL1 Lipoproteins,VLDL2 Lipoproteins,VLDL3 Lipoproteins,Very Low Density Lipoproteins
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D001055 Apolipoproteins B Major structural proteins of triacylglycerol-rich LIPOPROTEINS. There are two forms, apolipoprotein B-100 and apolipoprotein B-48, both derived from a single gene. ApoB-100 expressed in the liver is found in low-density lipoproteins (LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL). ApoB-48 expressed in the intestine is found in CHYLOMICRONS. They are important in the biosynthesis, transport, and metabolism of triacylglycerol-rich lipoproteins. Plasma Apo-B levels are high in atherosclerotic patients but non-detectable in ABETALIPOPROTEINEMIA. Apo-B,Apo B,ApoB,Apoprotein (B),Apoproteins B

Related Publications

Y Maynard, and D C Roden, and M J Tikkanen, and G Schonfeld, and J H Ladenson
January 1985, Progress in clinical and biological research,
Y Maynard, and D C Roden, and M J Tikkanen, and G Schonfeld, and J H Ladenson
August 1985, Canadian journal of biochemistry and cell biology = Revue canadienne de biochimie et biologie cellulaire,
Y Maynard, and D C Roden, and M J Tikkanen, and G Schonfeld, and J H Ladenson
July 1988, Journal of lipid research,
Y Maynard, and D C Roden, and M J Tikkanen, and G Schonfeld, and J H Ladenson
January 1986, Clinica chimica acta; international journal of clinical chemistry,
Y Maynard, and D C Roden, and M J Tikkanen, and G Schonfeld, and J H Ladenson
January 1987, Advances in experimental medicine and biology,
Y Maynard, and D C Roden, and M J Tikkanen, and G Schonfeld, and J H Ladenson
October 1984, Journal of steroid biochemistry,
Y Maynard, and D C Roden, and M J Tikkanen, and G Schonfeld, and J H Ladenson
March 1984, Clinical chemistry,
Y Maynard, and D C Roden, and M J Tikkanen, and G Schonfeld, and J H Ladenson
January 1999, Journal of lipid research,
Y Maynard, and D C Roden, and M J Tikkanen, and G Schonfeld, and J H Ladenson
July 1989, Clinical chemistry,
Copied contents to your clipboard!